| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs649129 | ADSGEGDFXAEGGGVR* / ADpSGEGDFXAEGGGVR* | T/C | 3788 | 0.22 | -0.085 (0.007) | 9.26·10-37 | show |
| rs495828 | DSGEGDFXAEGGGVR* / ADpSGEGDFXAEGGGVR* | T/G | 3777 | 0.22 | -0.088 (0.007) | 5.86·10-34 | show |
| rs579459 | ADpSGEGDFXAEGGGVR* / X-14304--leucylalanine | T/C | 2390 | 0.79 | -0.124 (0.011) | 1.21·10-28 | show |
| rs651007 | ADpSGEGDFXAEGGGVR* | T/C | 3845 | 0.21 | 0.065 (0.007) | 6.34·10-20 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs579459 |
| Chromosomal location | Chr9: 135,144,125 (9q34.2) |
| Gene (distance) | ABO (3,539) |
| Predicted causal gene | ABO |
| Gene/protein classification | - |
| Metabolite (Pathway) | ADSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) ADpSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) |
| Biochemical locus-metabolite relationship | ABO encodes a glycosyltransferase that determines the blood group. ABO blood group contributes to von Willebrand Factor levels perhaps by protecting it from susceptibility to ADAMTS13-mediated proteolysis. As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair. ALPL plausibly affects phosphorylation state of fibrinogen ('activity'). |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | Angiotensin-converting enzyme activity [20066004]; Cholesterol, total [20686565]; Coronary heart disease [21378990]; E-selectin levels [20147318]; End-stage coagulation [23381943]; LDL cholesterol [20686565]; Liver enzyme levels (alkaline phosphatase) [22001757]; Red blood cell traits [23222517]; Soluble E-selectin levels [19729612]; Soluble levels of adhesion molecules [20167578]; Venous thromboembolism [22672568] |
| Known metabolite associations | ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157] (r2=0.384 with rs612169); Metabolite levels [21909109] |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








